{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:36Z","timestamp":1784332836311,"version":"3.55.0"},"reference-count":99,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Bladder cancer, a life-threatening serious disease, is responsible for thousands of cancer-associated\ndeaths worldwide. Similar to other malignancies, standard treatments of bladder cancer, such as Chemoradiotherapy,\nare not efficient enough in the affected patients. It means that, according to recent reports in the\ncase of life quality as well as the survival time of bladder cancer patients, there is a critical requirement for\nexploring effective treatments. Recently, numerous investigations have been carried out to search for appropriate\ncomplementary treatments or adjuvants for bladder cancer therapy. Curcumin, a phenolic component with a\nwide spectrum of biological activities, has recently been introduced as a potential anti-cancer agent. It has been\nshown that this agent exerts its therapeutic effects via targeting a wide range of cellular and molecular pathways\ninvolved in bladder cancer. Herein, the current data on curcumin therapy for bladder cancer are summarized.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520620666200807223832","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T12:21:07Z","timestamp":1596889267000},"page":"587-596","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Therapeutic Applications of Curcumin and its Novel Formulations in the Treatment of Bladder Cancer: A Review of Current Evidence"],"prefix":"10.2174","volume":"21","author":[{"given":"Mohammad H.","family":"Pourhanifeh","sequence":"first","affiliation":[{"name":"Halal Research Center of IRI, FDA, Tehran,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mottaghi","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Kashan University of Medical Sciences, Kashan,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra S.","family":"Razavi","sequence":"additional","affiliation":[{"name":"School of Medicine, Kashan University of Medical Sciences, Kashan,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alimohammad","family":"Shafiee","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Toronto General Hospital, Toronto, ON,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hajighadimi","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Toronto General Hospital, Toronto, ON,Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mirzaei","sequence":"additional","affiliation":[{"name":"Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"35","volume":"14","author":"Luqmani Y.A.","year":"2005","unstructured":"Luqmani Y.A.; Mechanisms of drug resistance in cancer chemotherapy, Medical principles and practice: International journal of the Kuwait University. Health Sci Centre 2005,14(Suppl. 1),35-48","journal-title":"Health Sci Centre"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0022-5347(05)65468-7","volume":"167","author":"B&#xF6;hle A.","year":"2002","unstructured":"B&#xF6;hle A.; Jurczok A.; Ardelt P.; Wulf T.; Ulmer A.J.; Jocham D.; Brandau S.; Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in vivo. J Urol 2002,167(1),357-363","journal-title":"J Urol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"Sylvester R.J.","year":"2016","unstructured":"Sylvester R.J.; Oosterlinck W.; Holmang S.; Sydes M.R.; Birtle A.; Gudjonsson S.; De Nunzio C.; Okamura K.; Kaasinen E.; Solsona E.; Ali-El-Dein B.; Tatar C.A.; Inman B.A.; N\u2019Dow J.; Oddens J.R.; Babjuk M.; Systematic review and individual patient data meta-analysis of randomized trials comparing a single immediate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pTa-pT1 urothelial carcinoma of the bladder: Which patients benefit from the instillation? Eur Urol 2016,69(2),231-244","journal-title":"Eur Urol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.eururo.2013.06.009","volume":"64","author":"Perlis N.","year":"2013","unstructured":"Perlis N.; Zlotta A.R.; Beyene J.; Finelli A.; Fleshner N.E.; Kulkarni G.S.; Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: An updated meta-analysis on 2548 patients and quality-of-evidence review. Eur Urol 2013,64(3),421-430","journal-title":"Eur Urol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrurol.2017.30","volume":"14","author":"Nguyen D.P.","year":"2017","unstructured":"Nguyen D.P.; Thalmann G.N.; Contemporary update on neoadjuvant therapy for bladder cancer. Nat Rev Urol 2017,14(6),348-358","journal-title":"Nat Rev Urol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07357907.2016.1247166","volume":"35","author":"Allegra A.","year":"2017","unstructured":"Allegra A.; Innao V.; Russo S.; Gerace D.; Alonci A.; Musolino C.; Anticancer activity of curcumin and its analogues: Preclinical and clinical studies. Cancer Invest 2017,35(1),1-22","journal-title":"Cancer Invest"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/ijc.31947","volume":"144","author":"Hesari A.","year":"2019","unstructured":"Hesari A.; Azizian M.; Sheikhi A.; Nesaei A.; Sanaei S.; Mahinparvar N.; Derakhshani M.; Hedayt P.; Ghasemi F.; Mirzaei H.; Chemopreventive and therapeutic potential of curcumin in esophageal cancer: Current and future status. Int J Cancer 2019,144(6),1215-1226","journal-title":"Int J Cancer"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.canlet.2008.03.009","volume":"269","author":"Kunnumakkara A.B.","year":"2008","unstructured":"Kunnumakkara A.B.; Anand P.; Aggarwal B.B.; Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008,269(2),199-225","journal-title":"Cancer Lett"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","volume":"41","author":"Aggarwal B.B.","year":"2009","unstructured":"Aggarwal B.B.; Harikumar K.B.; Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009,41(1),40-59","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=10","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152556","volume":"215","author":"Ghasemi F.","year":"2019","unstructured":"Ghasemi F.; Shafiee M.; Banikazemi Z.; Pourhanifeh M.H.; Khanbabaei H.; Shamshirian A.; Amiri Moghadam S.; ArefNezhad, R.; Sahebkar, A.; Avan, A.; Mirzaei, H. Curcumin inhibits NF-kB and Wnt\/&#x3B2;-catenin pathways in cervical cancer cells. Pathol Res Pract 2019,215(10)","journal-title":"Pathol Res Pract"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104353","volume":"147","author":"Shafabakhsh R.","year":"2019","unstructured":"Shafabakhsh R.; Pourhanifeh M.H.; Mirzaei H.R.; Sahebkar A.; Asemi Z.; Mirzaei H.; Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy. Pharmacol Res 2019,147","journal-title":"Pharmacol Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1590\/S1807-59322011001200019","volume":"66","author":"Watanabe F.T.","year":"2011","unstructured":"Watanabe F.T.; Chade D.C.; Reis S.T.; Piantino C.; Dall\u2019 Oglio, M.F.; Srougi, M.; Leite, K.R. Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model. Clinics (S&#xE3;o Paulo) 2011,66(12),2121-2124","journal-title":"Clinics (S&#xE3;o Paulo)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"8958","DOI":"10.1158\/0008-5472.CAN-09-2045","volume":"69","author":"Kamat A.M.","year":"2009","unstructured":"Kamat A.M.; Tharakan S.T.; Sung B.; Aggarwal B.B.; Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors. Cancer Res 2009,69(23),8958-8966","journal-title":"Cancer Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"63870","DOI":"10.18632\/oncotarget.11563","volume":"7","author":"Park B.H.","year":"2016","unstructured":"Park B.H.; Lim J.E.; Jeon H.G.; Seo S.I.; Lee H.M.; Choi H.Y.; Jeon S.S.; Jeong B.C.; Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1\/2. Oncotarget 2016,7(39),63870-63886","journal-title":"Oncotarget"},{"key":"ref=15","first-page":"737","volume":"27","author":"Hauser P.J.","year":"2007","unstructured":"Hauser P.J.; Han Z.; Sindhwani P.; Hurst R.E.; Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix. Anticancer Res 2007,27(2),737-740","journal-title":"Anticancer Res"},{"key":"ref=16","author":"Kumar V.","year":"2014","unstructured":"Kumar V.; Abbas A.K.; Fausto N.; Aster J.C.;  Robbins and Cotran pathologic basis of disease, professional edition e-book 2014","journal-title":"Robbins and Cotran pathologic basis of disease, professional edition e-book"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jamainternmed.2017.8625","volume":"178","author":"Christensen C.H.","year":"2018","unstructured":"Christensen C.H.; Rostron B.; Cosgrove C.; Altekruse S.F.; Hartman A.M.; Gibson J.T.; Apelberg B.; Inoue-Choi M.; Freedman N.D.; Association of cigarette, cigar, and pipe use with mortality risk in the US population. JAMA Intern Med 2018,178(4),469-476","journal-title":"JAMA Intern Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","volume":"71","author":"Alfred Witjes J.","year":"2017","unstructured":"Alfred Witjes J.; Lebret T.; Comp&#xE9;rat E.M.; Cowan N.C.; De Santis M.; Bruins H.M.; Hern&#xE1;ndez V.; Espin&#xF3;s E.L.; Dunn J.; Rouanne M.; Neuzillet Y.; Veskim&#xE4;e E.; van der Heijden A.G.; Gakis G.; Ribal M.J.; Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2017,71(3),462-475","journal-title":"Eur Urol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"iii40","DOI":"10.1093\/annonc\/mdu223","volume":"25","author":"Bellmunt J.","year":"2014","unstructured":"Bellmunt J.; Orsola A.; Leow J.J.; Wiegel T.; De Santis M.; Horwich A.; Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol ESMO Guidelines Working Group2014,25(Suppl. 3),iii40-iii48","journal-title":"Ann Oncol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"Babjuk M.","year":"2017","unstructured":"Babjuk M.; B&#xF6;hle A.; Burger M.; Capoun O.; Cohen D.; Comp&#xE9;rat E.M.; Hern&#xE1;ndez V.; Kaasinen E.; Palou J.; Roupr&#xEA;t M.; van Rhijn B.W.; Shariat S.F.; Soukup V.; Sylvester R.J.; Zigeuner R.; EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol 2017,71(3),447-461","journal-title":"Eur Urol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1002\/cncr.24466","volume":"115","author":"Sonpavde G.","year":"2009","unstructured":"Sonpavde G.; Goldman B.H.; Speights V.O.; Lerner S.P.; Wood D.P.; Vogelzang N.J.; Trump D.L.; Natale R.B.; Grossman H.B.; Crawford E.D.; Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy. Cancer 2009,115(18),4104-4109","journal-title":"Cancer"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.eururo.2017.06.038","volume":"73","author":"Bosschieter J.","year":"2018","unstructured":"Bosschieter J.; Nieuwenhuijzen J.A.; van Ginkel T.; Vis A.N.; Witte B.; Newling D.; Beckers G.M.A.; van Moorselaar R.J.A.; Value of an immediate intravesical instillation of Mitomycin C in patients with non-muscle-invasive bladder cancer: A prospective multicentre randomised study in 2243 patients. Eur Urol 2018,73(2),226-232","journal-title":"Eur Urol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1001\/jama.2018.4657","volume":"319","author":"Messing E.M.","year":"2018","unstructured":"Messing E.M.; Tangen C.M.; Lerner S.P.; Sahasrabudhe D.M.; Koppie T.M.; Wood D.P.; Mack P.C.; Svatek R.S.; Evans C.P.; Hafez K.S.; Culkin D.J.; Brand T.C.; Karsh L.I.; Holzbeierlein J.M.; Wilson S.S.; Wu G.; Plets M.; Vogelzang N.J.; Thompson I.M.; Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non-muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial. JAMA 2018,319(18),1880-1888","journal-title":"JAMA"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009294.pub2","volume":"1","author":"Jones G.","year":"2012","unstructured":"Jones G.; Cleves A.; Wilt T.J.; Mason M.; Kynaston H.G.; Shelley M.; Intravesical gemcitabine for non-muscle invasive bladder cancer. Cochrane Database Syst Rev 2012,1","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1464-410X.2003.04655.x","volume":"93","author":"Shelley M.D.","year":"2004","unstructured":"Shelley M.D.; Wilt T.J.; Court J.; Coles B.; Kynaston H.; Mason M.D.; Intravesical Bacillus Calmette-Gu&#xE9;rin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: A meta-analysis of randomized trials. BJU Int 2004,93(4),485-490","journal-title":"BJU Int"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0022-5347(05)64043-8","volume":"169","author":"B&#xF6;hle A.","year":"2003","unstructured":"B&#xF6;hle A.; Jocham D.; Bock P.R.; Intravesical Bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: A formal meta-analysis of comparative studies on recurrence and toxicity. J Urol 2003,169(1),90-95","journal-title":"J Urol"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.biopha.2016.11.098","volume":"85","author":"Mirzaei H.","year":"2017","unstructured":"Mirzaei H.; Shakeri A.; Rashidi B.; Jalili A.; Banikazemi Z.; Sahebkar A.; Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomed Pharmacother 2017,85,102-112","journal-title":"Biomed Pharmacother"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"Anand P.","year":"2007","unstructured":"Anand P.; Kunnumakkara A.B.; Newman R.A.; Aggarwal B.B.; Bioavailability of curcumin: Problems and promises. Mol Pharm 2007,4(6),807-818","journal-title":"Mol Pharm"},{"key":"ref=29","first-page":"1058","volume":"61","author":"Ireson C.","year":"2001","unstructured":"Ireson C.; Orr S.; Jones D.J.; Verschoyle R.; Lim C.K.; Luo J.L.; Howells L.; Plummer S.; Jukes R.; Williams M.; Steward W.P.; Gescher A.; Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 2001,61(3),1058-1064","journal-title":"Cancer Res"},{"key":"ref=30","first-page":"486","volume":"27","author":"Pan M.H.","year":"1999","unstructured":"Pan M.H.; Huang T.M.; Lin J.K.; Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 1999,27(4),486-494","journal-title":"Drug Metab Dispos"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1600-0773.1978.tb02240.x","volume":"43","author":"Wahlstr&#xF6;m B.","year":"1978","unstructured":"Wahlstr&#xF6;m B.; Blennow G.; A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 1978,43(2),86-92","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/978-0-387-46401-5_20","author":"Sharma R.A.","year":"2007","unstructured":"Sharma R.A.; Steward W.P.; Gescher A.J.;  The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease 2007,453-470","journal-title":"The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0300-483X(80)90122-5","volume":"16","author":"Ravindranath V.","year":"1980","unstructured":"Ravindranath V.; Chandrasekhara N.; Absorption and tissue distribution of curcumin in rats. Toxicology 1980,16(3),259-265","journal-title":"Toxicology"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0300-483X(81)90056-1","volume":"20","author":"Ravindranath V.","year":"1981","unstructured":"Ravindranath V.; Chandrasekhara N.; In vitro studies on the intestinal absorption of curcumin in rats. Toxicology 1981,20(2-3),251-257","journal-title":"Toxicology"},{"key":"ref=35","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/678218","volume":"2015","author":"Gutierres V.O.","year":"2015","unstructured":"Gutierres V.O.; Campos M.L.; Arcaro C.A.; Assis R.P.; Baldan-Cimatti H.M.; Peccinini R.G.; Paula-Gomes S.; Kettelhut I.C.; Baviera A.M.; Brunetti I.L.; Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s). Evid Based Complement Alternat Med 2015,2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-511X-11-3","volume":"11","author":"K&#xFC;llenberg D.","year":"2012","unstructured":"K&#xFC;llenberg D.; Taylor L.A.; Schneider M.; Massing U.; Health effects of dietary phospholipids. Lipids Health Dis 2012,11,3","journal-title":"Lipids Health Dis"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.3748\/wjg.v19.i20.3007","volume":"19","author":"Grattagliano I.","year":"2013","unstructured":"Grattagliano I.; Diogo C.V.; Mastrodonato M.; de Bari O.; Persichella M.; Wang D.Q.; Liquori A.; Ferri D.; Carrat&#xF9; M.R.; Oliveira P.J.; Portincasa P.; A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes. World J Gastroenterol 2013,19(20),3007-3017","journal-title":"World J Gastroenterol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF03188811","volume":"18","author":"Morazzoni P.","year":"1993","unstructured":"Morazzoni P.; Montalbetti A.; Malandrino S.; Pifferi G.; Comparative pharmacokinetics of silipide and silymarin in rats. Eur J Drug Metab Pharmacokinet 1993,18(3),289-297","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1254\/jjp.60.315","volume":"60","author":"Conti M.","year":"1992","unstructured":"Conti M.; Malandrino S.; Magistretti M.J.; Protective activity of silipide on liver damage in rodents. Jpn J Pharmacol 1992,60(4),315-321","journal-title":"Jpn J Pharmacol"},{"key":"ref=40","first-page":"84","volume":"4","author":"Maiti K.","year":"2005","unstructured":"Maiti K.; Mukherjee K.; Gantait A.; Ahamed H.N.; Saha B.P.; Mukherjee P.K.; Enhanced therapeutic benefit of quercetinphospholipid complex in carbon tetrachloride-induced acute liver injury in rats: A comparative study. Iran. J Pharmacol Therapeut 2005,4,84-90","journal-title":"J Pharmacol Therapeut"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1021\/np1007262","volume":"74","author":"Cuomo J.","year":"2011","unstructured":"Cuomo J.; Appendino G.; Dern A.S.; Schneider E.; McKinnon T.P.; Brown M.J.; Togni S.; Dixon B.M.; Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod 2011,74(4),664-669","journal-title":"J Nat Prod"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/bab.1836","volume":"67","author":"Bashang H.","year":"2020","unstructured":"Bashang H.; Tamma S.; The use of curcumin as an effective adjuvant to cancer therapy: A short review. Biotechnol Appl Biochem 2020,67(2),171-179","journal-title":"Biotechnol Appl Biochem"},{"key":"ref=43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112040","volume":"188","author":"Shabaninejad Z.","year":"2020","unstructured":"Shabaninejad Z.; Pourhanifeh M.H.; Movahedpour A.; Mottaghi R.; Nickdasti A.; Mortezapour E.; Shafiee A.; Hajighadimi S.; Moradizarmehri S.; Sadeghian M.; Mousavi S.M.; Mirzaei H.; Therapeutic potentials of curcumin in the treatment of glioblstoma. Eur J Med Chem 2020,188","journal-title":"Eur J Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"484","DOI":"10.4062\/biomolther.2019.107","volume":"27","author":"Lee J.E.","year":"2019","unstructured":"Lee J.E.; Yoon S.S.; Moon E.Y.; Curcumin-induced autophagy augments its antitumor effect against A172 human glioblastoma cells. Biomol Ther (Seoul) 2019,27(5),484-491","journal-title":"Biomol Ther (Seoul)"},{"key":"ref=45","first-page":"5820","volume":"11","author":"Liu W.","year":"2018","unstructured":"Liu W.; Huang M.; Zou Q.; Lin W.; Curcumin suppresses gastric cancer biological activity by regulation of miRNA-21: An in vitro study. Int J Clin Exp Pathol 2018,11(12),5820-5829","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3349\/ymj.2020.61.1.20","volume":"61","author":"Chen L.","year":"2020","unstructured":"Chen L.; Zhan C.Z.; Wang T.; You H.; Yao R.; Curcumin inhibits the proliferation, migration, invasion, and apoptosis of diffuse large B-cell lymphoma cell line by regulating MiR-21\/VHL axis. Yonsei Med J 2020,61(1),20-29","journal-title":"Yonsei Med J"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fphys.2015.00129","volume":"6","author":"Halder R.C.","year":"2015","unstructured":"Halder R.C.; Almasi A.; Sagong B.; Leung J.; Jewett A.; Fiala M.; Curcuminoids and &#x3C9;-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon &#x3B3; production. Front Physiol 2015,6,129","journal-title":"Front Physiol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jhep.2015.04.018","volume":"63","author":"Marquardt J.U.","year":"2015","unstructured":"Marquardt J.U.; Gomez-Quiroz L.; Arreguin Camacho L.O.; Pinna F.; Lee Y.H.; Kitade M.; Dom&#xED;nguez M.P.; Castven D.; Breuhahn K.; Conner E.A.; Galle P.R.; Andersen J.B.; Factor V.M.; Thorgeirsson S.S.; Curcumin effectively inhibits oncogenic NF-&#x3BA;B signaling and restrains stemness features in liver cancer. J Hepatol 2015,63(3),661-669","journal-title":"J Hepatol"},{"key":"ref=49","first-page":"1487","volume":"24","author":"Calibasi-Kocal G.","year":"2019","unstructured":"Calibasi-Kocal G.; Pakdemirli A.; Bayrak S.; Ozupek N.M.; Sever T.; Basbinar Y.; Ellidokuz H.; Yigitbasi T.; Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer, Journal of B.U.ON. Off. J Balkan Union Oncol 2019,24,1487-1482","journal-title":"J Balkan Union Oncol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"17784","DOI":"10.1038\/s41598-019-54284-x","volume":"9","author":"G&#xF6;k&#xE7;e K&#xFC;t&#xFC;k S.","year":"2019","unstructured":"G&#xF6;k&#xE7;e K&#xFC;t&#xFC;k S.; G&#xF6;k&#xE7;e G.; K&#xFC;t&#xFC;k M.; G&#xFC;rses Cila H.E.; Naz\u0131ro&#x11F;lu M.; Curcumin enhances cisplatin-induced human laryngeal squamous cancer cell death through activation of TRPM2 channel and mitochondrial oxidative stress. Sci Rep 2019,9(1),17784","journal-title":"Sci Rep"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9634902","volume":"2018","author":"Falke J.","year":"2018","unstructured":"Falke J.; Parkkinen J.; Vaahtera L.; Hulsbergen-van de Kaa C.A.; Oosterwijk E.; Witjes J.A.; Curcumin as treatment for bladder cancer: A preclinical study of cyclodextrin-curcumin complex and BCG as intravesical treatment in an orthotopic bladder cancer rat model. BioMed Res Int 2018,2018","journal-title":"BioMed Res Int"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4021\/wjon335w","volume":"2","author":"Wang J.","year":"2011","unstructured":"Wang J.; Wang Z.; Wang H.; Zhao J.; Zhang Z.; Curcumin induces apoptosis in EJ bladder cancer cells via modulating c-myc and PI3K\/Akt signaling Pathway. World J Oncol 2011,2(3),113-122","journal-title":"World J Oncol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cytogfr.2015.01.002","volume":"26","author":"Brouwer-Visser J.","year":"2015","unstructured":"Brouwer-Visser J.; Huang G.S.; IGF2 signaling and regulation in cancer. Cytokine Growth Factor Rev 2015,26(3),371-377","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3892\/or.2015.4048","volume":"34","author":"Dong Y.","year":"2015","unstructured":"Dong Y.; Li J.; Han F.; Chen H.; Zhao X.; Qin Q.; Shi R.; Liu J.; High IGF2 expression is associated with poor clinical outcome in human ovarian cancer. Oncol Rep 2015,34(2),936-942","journal-title":"Oncol Rep"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ng.3722","volume":"49","author":"Weischenfeldt J.","year":"2017","unstructured":"Weischenfeldt J.; Dubash T.; Drainas A.P.; Mardin B.R.; Chen Y.; St&#xFC;tz A.M.; Waszak S.M.; Bosco G.; Halvorsen A.R.; Raeder B.; Efthymiopoulos T.; Erkek S.; Siegl C.; Brenner H.; Brustugun O.T.; Dieter S.M.; Northcott P.A.; Petersen I.; Pfister S.M.; Schneider M.; Solberg S.K.; Thunissen E.; Weichert W.; Zichner T.; Thomas R.; Peifer M.; Helland A.; Ball C.R.; Jechlinger M.; Sotillo R.; Glimm H.; Korbel J.O.; Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking. Nat Genet 2017,49(1),65-74","journal-title":"Nat Genet"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/cpr.12106","volume":"47","author":"Nordin M.","year":"2014","unstructured":"Nordin M.; Bergman D.; Halje M.; Engstr&#xF6;m W.; Ward A.; Epigenetic regulation of the Igf2\/H19 gene cluster. Cell Prolif 2014,47(3),189-199","journal-title":"Cell Prolif"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.cellbi.2008.07.007","volume":"32","author":"Hamamura K.","year":"2008","unstructured":"Hamamura K.; Zhang P.; Yokota H.; IGF2-driven PI3 kinase and TGFbeta signaling pathways in chondrogenesis. Cell Biol Int 2008,32(10),1238-1246","journal-title":"Cell Biol Int"},{"key":"ref=58","first-page":"59","volume":"1","author":"Leick M.B.","year":"2011","unstructured":"Leick M.B.; Shoff C.J.; Wang E.C.; Congress J.L.; Gallicano G.I.; Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer. Am J Stem Cells 2011,1(1),59-74","journal-title":"Am J Stem Cells"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1080\/1061186X.2017.1306535","volume":"25","author":"Tian B.","year":"2017","unstructured":"Tian B.; Zhao Y.; Liang T.; Ye X.; Li Z.; Yan D.; Fu Q.; Li Y.; Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K\/AKT\/mTOR signaling pathway. J Drug Target 2017,25(7),626-636","journal-title":"J Drug Target"},{"key":"ref=60","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317702548","volume":"39","author":"Shi J.","year":"2017","unstructured":"Shi J.; Wang Y.; Jia Z.; Gao Y.; Zhao C.; Yao Y.; Curcumin inhibits bladder cancer progression via regulation of &#x3B2;-catenin expression. Tumour Biol 2017,39(7)","journal-title":"Tumour Biol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbrc.2017.08.158","volume":"493","author":"Wang D.","year":"2017","unstructured":"Wang D.; Kong X.; Li Y.; Qian W.; Ma J.; Wang D.; Yu D.; Zhong C.; Curcumin inhibits bladder cancer stem cells by suppressing Sonic Hedgehog pathway. Biochem Biophys Res Commun 2017,493(1),521-527","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3892\/ijo.2018.4423","volume":"53","author":"Zhang L.","year":"2018","unstructured":"Zhang L.; Yang G.; Zhang R.; Dong L.; Chen H.; Bo J.; Xue W.; Huang Y.; Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells. Int J Oncol 2018,53(2),515-526","journal-title":"Int J Oncol"},{"key":"ref=63","first-page":"10564","volume":"23","author":"Mani J.","year":"2019","unstructured":"Mani J.; Fleger J.; Rutz J.; Maxeiner S.; Bernd A.; Kippenberger S.; Z&#xF6;ller N.; Chun F.K.; Relja B.; Juengel E.; Blaheta R.A.; Curcumin combined with exposure to visible light blocks bladder cancer cell adhesion and migration by an integrin dependent mechanism. Eur Rev Med Pharmacol Sci 2019,23(23),10564-10574","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"6869","DOI":"10.3892\/ol.2019.11023","volume":"18","author":"Cho C.J.","year":"2019","unstructured":"Cho C.J.; Yang C.W.; Wu C.L.; Ho J.Y.; Yu C.P.; Wu S.T.; Yu D.S.; The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol. Oncol Lett 2019,18(6),6869-6876","journal-title":"Oncol Lett"},{"key":"ref=65","first-page":"3225","volume":"18","author":"Afsharmoghadam N.","year":"2017","unstructured":"Afsharmoghadam N.; Haghighatian Z.; Mazdak H.; Mirkheshti N.; Mehrabi Koushki R.; Alavi S.A.; Concentration-dependent effects of curcumin on 5-fluorouracil efficacy in bladder cancer cells. Asian Pac J Cancer Prev 2017,18(12),3225-3230","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3892\/ol.2017.6205","volume":"14","author":"Shi J.","year":"2017","unstructured":"Shi J.; Zhang X.; Shi T.; Li H.; Antitumor effects of curcumin in human bladder cancer in vitro. Oncol Lett 2017,14(1),1157-1161","journal-title":"Oncol Lett"},{"key":"ref=67","first-page":"884","volume":"21","author":"Pan Z.J.","year":"2017","unstructured":"Pan Z.J.; Deng N.; Zou Z.H.; Chen G.X.; The effect of curcumin on bladder tumor in rat model. Eur Rev Med Pharmacol Sci 2017,21(4),884-889","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=68","first-page":"215","volume":"68","author":"Sun X.","year":"2016","unstructured":"Sun X.; Deng Q.F.; Liang Z.F.; Zhang Z.Q.; Zhao L.; Geng H.; Xie D.D.; Wang Y.; Yu D.X.; Zhong C.Y.; Curcumin reverses benzidine-induced cell proliferation by suppressing ERK1\/2 pathway in human bladder cancer T24 cells, Experimental and toxicologic pathology. Off. J Gesellschaft Toxikol Pathol 2016,68,215-222","journal-title":"J Gesellschaft Toxikol Pathol"},{"key":"ref=69","first-page":"4503","volume":"8","author":"Liang Z.","year":"2015","unstructured":"Liang Z.; Xie W.; Wu R.; Geng H.; Zhao L.; Xie C.; Li X.; Zhu M.; Zhu W.; Zhu J.; Huang C.; Ma X.; Wu J.; Geng S.; Zhong C.; Han H.; Inhibition of tobacco smoke-induced bladder MAPK activation and epithelial-mesenchymal transition in mice by curcumin. Int J Clin Exp Pathol 2015,8(5),4503-4513","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=70","first-page":"2043","volume":"37","author":"Zhang S.N.","year":"2014","unstructured":"Zhang S.N.; Yong Q.; Wu X.L.; Liu X.P.; Synergism inhibition of curcumin combined with cisplatin on T24 bladder carcinoma cells and its related mechanism. Zhong Yao Cai 2014,37(11),2043-2046","journal-title":"Zhong Yao Cai"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"15173","DOI":"10.3390\/ijms150915173","volume":"15","author":"Gao Y.","year":"2014","unstructured":"Gao Y.; Shi Q.; Xu S.; Du C.; Liang L.; Wu K.; Wang K.; Wang X.; Chang L.S.; He D.; Guo P.; Curcumin promotes KLF5 proteasome degradation through downregulating YAP\/TAZ in bladder cancer cells. Int J Mol Sci 2014,15(9),15173-15187","journal-title":"Int J Mol Sci"},{"key":"ref=72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048567","volume":"7","author":"Pichu S.","year":"2012","unstructured":"Pichu S.; Krishnamoorthy S.; Shishkov A.; Zhang B.; McCue P.; Ponnappa B.C.; Knockdown of Ki-67 by dicer-substrate small interfering RNA sensitizes bladder cancer cells to curcumin-induced tumor inhibition. PLoS One 2012,7(11)","journal-title":"PLoS One"},{"key":"ref=73","first-page":"3530","volume":"50","author":"Wu S.Y.","year":"2012","unstructured":"Wu S.Y.; Lee Y.R.; Huang C.C.; Li Y.Z.; Chang Y.S.; Yang C.Y.; Wu J.D.; Liu Y.W.; Curcumin-induced heme oxygenase-1 expression plays a negative role for its anti-cancer effect in bladder cancers, Food and chemical toxicology. Int J Publ Brit Indust Biol Res Assoc 2012,50,3530-3536","journal-title":"Int J Publ Brit Indust Biol Res Assoc"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1124\/mol.111.072512","volume":"80","author":"Liu H.S.","year":"2011","unstructured":"Liu H.S.; Ke C.S.; Cheng H.C.; Huang C.Y.; Su C.L.; Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of aurora A. Mol Pharmacol 2011,80(4),638-646","journal-title":"Mol Pharmacol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1158\/1541-7786.MCR-09-0493","volume":"8","author":"Chadalapaka G.","year":"2010","unstructured":"Chadalapaka G.; Jutooru I.; Burghardt R.; Safe S.; Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells. Mol Cancer Res 2010,8(5),739-750","journal-title":"Mol Cancer Res"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1590\/S1677-55382009000500012","volume":"35","author":"Leite K.R.","year":"2009","unstructured":"Leite K.R.; Chade D.C.; Sanudo A.; Sakiyama B.Y.; Batocchio G.; Srougi M.; Effects of curcumin in an orthotopic murine bladder tumor model. Int Braz J Urol 2009,35,599-606","journal-title":"Int Braz J Urol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1158\/0008-5472.CAN-07-6805","volume":"68","author":"Chadalapaka G.","year":"2008","unstructured":"Chadalapaka G.; Jutooru I.; Chintharlapalli S.; Papineni S.; Smith R.; Li X.; Safe S.; Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res 2008,68(13),5345-5354","journal-title":"Cancer Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.canlet.2008.01.041","volume":"264","author":"Tian B.","year":"2008","unstructured":"Tian B.; Wang Z.; Zhao Y.; Wang D.; Li Y.; Ma L.; Li X.; Li J.; Xiao N.; Tian J.; Rodriguez R.; Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. Cancer Lett 2008,264(2),299-308","journal-title":"Cancer Lett"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1158\/1535-7163.MCT-06-0545","volume":"6","author":"Kamat A.M.","year":"2007","unstructured":"Kamat A.M.; Sethi G.; Aggarwal B.B.; Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells. Mol Cancer Ther 2007,6(3),1022-1030","journal-title":"Mol Cancer Ther"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3892\/or.15.5.1225","volume":"15","author":"Park C.","year":"2006","unstructured":"Park C.; Kim G.Y.; Kim G.D.; Choi B.T.; Park Y.M.; Choi Y.H.; Induction of G2\/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. Oncol Rep 2006,15(5),1225-1231","journal-title":"Oncol Rep"},{"key":"ref=81","first-page":"848","volume":"27","author":"Sun M.","year":"2004","unstructured":"Sun M.; Yang Y.; Li H.; Su B.; Lu Y.; Wei Q.; Fan T.; The effect of curcumin on bladder cancer cell line EJ in vitro. Zhong Yao Cai 2004,27(11),848-850","journal-title":"Zhong Yao Cai"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0022-5347(05)65819-3","volume":"166","author":"Sindhwani P.","year":"2001","unstructured":"Sindhwani P.; Hampton J.A.; Baig M.M.; Keck R.; Selman S.H.; Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice. J Urol 2001,166(4),1498-1501","journal-title":"J Urol"},{"key":"ref=83","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6374940","volume":"2019","author":"Roos F.","year":"2019","unstructured":"Roos F.; Binder K.; Rutz J.; Maxeiner S.; Bernd A.; Kippenberger S.; Zoller N.; Chun F.K.; Juengel E.; Blaheta R.A.; The antitumor effect of curcumin in urothelial cancer cells is enhanced by light exposure in vitro. Evid Based Complement Alternat Med 2019,2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s11255-019-02210-5","volume":"51","author":"Xu R.","year":"2019","unstructured":"Xu R.; Li H.; Wu S.; Qu J.; Yuan H.; Zhou Y.; Lu Q.; MicroRNA-1246 regulates the radio-sensitizing effect of curcumin in bladder cancer cells via activating P53. Int Urol Nephrol 2019,51(10),1771-1779","journal-title":"Int Urol Nephrol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1158\/1940-6207.CAPR-11-0267","volume":"4","author":"Saini S.","year":"2011","unstructured":"Saini S.; Arora S.; Majid S.; Shahryari V.; Chen Y.; Deng G.; Yamamura S.; Ueno K.; Dahiya R.; Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res (Phila) 2011,4(10),1698-1709","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1142\/S0192415X18500714","volume":"46","author":"Wang K.","year":"2018","unstructured":"Wang K.; Tan S.L.; Lu Q.; Xu R.; Cao J.; Wu S.Q.; Wang Y.H.; Zhao X.K.; Zhong Z.H.; Curcumin suppresses microRNA-7641-mediated regulation of p16 expression in bladder cancer. Am J Chin Med 2018,46(6),1357-1368","journal-title":"Am J Chin Med"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.2147\/OTT.S130653","volume":"10","author":"Shao Y.","year":"2017","unstructured":"Shao Y.; Zhu W.; Da J.; Xu M.; Wang Y.; Zhou J.; Wang Z.; Bisdemethoxycurcumin in combination with &#x3B1;-PD-L1 antibody boosts immune response against bladder cancer. OncoTargets Ther 2017,10,2675-2683","journal-title":"OncoTargets Ther"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3892\/or.2015.4537","volume":"35","author":"Kang M.","year":"2016","unstructured":"Kang M.; Ho J.N.; Kook H.R.; Lee S.; Oh J.J.; Hong S.K.; Lee S.E.; Byun S.S.; Theracurmin&#xAE; efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest. Oncol Rep 2016,35(3),1463-1472","journal-title":"Oncol Rep"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00001813-200603000-00006","volume":"17","author":"Tong Q.S.","year":"2006","unstructured":"Tong Q.S.; Zheng L.D.; Lu P.; Jiang F.C.; Chen F.M.; Zeng F.Q.; Wang L.; Dong J.H.; Apoptosis-inducing effects of curcumin derivatives in human bladder cancer cells. Anticancer Drugs 2006,17(3),279-287","journal-title":"Anticancer Drugs"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/jcp.25795","volume":"233","author":"Ramezani M.","year":"2018","unstructured":"Ramezani M.; Hatamipour M.; Sahebkar A.; Promising anti-tumor properties of bisdemethoxycurcumin: A naturally occurring curcumin analogue. J Cell Physiol 2018,233(2),880-887","journal-title":"J Cell Physiol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1021\/acs.chemrestox.5b00009","volume":"28","author":"Gordon O.N.","year":"2015","unstructured":"Gordon O.N.; Luis P.B.; Ashley R.E.; Osheroff N.; Schneider C.; Oxidative transformation of demethoxy- and bisdemethoxycurcumin: Products, mechanism of formation, and poisoning of human topoisomerase II&#x3B1;. Chem Res Toxicol 2015,28(5),989-996","journal-title":"Chem Res Toxicol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/carcin\/bgm123","volume":"28","author":"Sandur S.K.","year":"2007","unstructured":"Sandur S.K.; Pandey M.K.; Sung B.; Ahn K.S.; Murakami A.; Sethi G.; Limtrakul P.; Badmaev V.; Aggarwal B.B.; Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 2007,28(8),1765-1773","journal-title":"Carcinogenesis"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"12849","DOI":"10.1073\/pnas.0701267104","volume":"104","author":"Fiala M.","year":"2007","unstructured":"Fiala M.; Liu P.T.; Espinosa-Jeffrey A.; Rosenthal M.J.; Bernard G.; Ringman J.M.; Sayre J.; Zhang L.; Zaghi J.; Dejbakhsh S.; Chiang B.; Hui J.; Mahanian M.; Baghaee A.; Hong P.; Cashman J.; Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer\u2019s disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci USA 2007,104(31),12849-12854","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3923\/ijp.2010.664.669","volume":"6","author":"Sivabalan S.","year":"2010","unstructured":"Sivabalan S.; Anuradha C.; A comparative study on the antioxidant and glucose-lowering effects of curcumin and bisdemethoxycurcumin analog through in vitro assays. Int J Pharmacol 2010,6,664-669","journal-title":"Int J Pharmacol"},{"key":"ref=95","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.270","volume":"4","author":"Lin T.H.","year":"2013","unstructured":"Lin T.H.; Izumi K.; Lee S.O.; Lin W.J.; Yeh S.; Chang C.; Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling. Cell Death Dis 2013,4","journal-title":"Cell Death Dis"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.ajpath.2013.01.018","volume":"182","author":"Hsu J.W.","year":"2013","unstructured":"Hsu J.W.; Hsu I.; Xu D.; Miyamoto H.; Liang L.; Wu X.R.; Shyr C.R.; Chang C.; Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor. Am J Pathol 2013,182(5),1811-1820","journal-title":"Am J Pathol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.1016\/j.bmc.2010.07.063","volume":"18","author":"Yadav B.","year":"2010","unstructured":"Yadav B.; Taurin S.; Rosengren R.J.; Schumacher M.; Diederich M.; Somers-Edgar T.J.; Larsen L.; Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin. Bioorg Med Chem 2010,18(18),6701-6707","journal-title":"Bioorg Med Chem"},{"key":"ref=98","first-page":"2","volume":"46","author":"Prasad S.","year":"2014","unstructured":"Prasad S.; Tyagi A.K.; Aggarwal B.B.; Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice, Cancer research and treatment. Off. J Korean Cancer Assoc 2014,46,2-18","journal-title":"J Korean Cancer Assoc"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"9547","DOI":"10.2147\/IJN.S225172","volume":"14","author":"Samaddar S.","year":"2019","unstructured":"Samaddar S.; Mazur J.; Boehm D.; Thompson D.H.; Development and in vitro characterization of bladder tumor cell targeted lipid-coated polyplex for dual delivery of plasmids and small molecules. Int J Nanomedicine 2019,14,9547-9561","journal-title":"Int J Nanomedicine"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/184682","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.eurekaselect.com\/184682\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/eurekaselect.com\/article\/download\/184682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,2]],"date-time":"2022-01-02T14:43:32Z","timestamp":1641134612000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/184682\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520620666200807223832","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}